尿蛋白

niào dàn bái
  • urinary protein
尿蛋白尿蛋白
  1. 于注射后两周测所有大鼠24小时尿蛋白定量,24小时尿蛋白定量>30mg为肾病模型成功而不合格者予以剔除。

    Two weeks after the injection , the excretion of 24 hrs urinary protein of all rats was detected and those with 24 hrs urinary protein > 30mg were chosen as nephropathic rats .

  2. 肾小管损伤的病理机制主要与尿蛋白毒性、炎症介质异常表达、血流动力学改变有关。

    The pathological mechanism of renal tubular injury mainly is related to the harmful factors of these pathological changes , such as urinary protein toxicity , abnormal expression of inflammatory mediators and changes of dynamics of blood flow .

  3. 慢性肾炎患者肾组织蛋白酶B的表达与尿蛋白的关系

    Relationship between expression of cathepsin B and urine protein in patients with chronic glomerular nephritis

  4. ELISA法检测孕妇四种尿蛋白含量变化

    Determination of four urinary proteins in pregnant women by ELISA

  5. 胰岛素和氨基胍可降低HbAGE水平,减少尿蛋白,阻止基底膜增厚。

    Insulin and aminoguanidine reduced Hb AGE levels , decreased urine protein and retarded basement membrane thickening .

  6. IgA肾病患者尿蛋白成分与临床病理指标的相关性

    Analysis the Relationship Between Urinary Protein Components and Clinical-Pathological Characteristics in IgA Nephropathy Patients

  7. 并测取24h尿蛋白含量;

    Urinary protein excretion was quantitated every 24 hours ;

  8. 24h尿蛋白定量明显增高;

    The quantity of the urinary protein in 24 hours was increased significantly .

  9. 随机尿蛋白与血清胱抑素C比值与24h尿蛋白定量的相关性研究

    Study on the correlation between the ratio of random urine protein to serum cystatin C and 24 - hour urine quantitative protein

  10. 观察治疗四周前后24h尿蛋白定量、尿红细胞计数变化。

    After 4 weeks , proteinuria and red blood cell count in urine were measured .

  11. 膜性肾病(MGN)患者血清VEGF与24h尿蛋白排泄量呈正相关。

    In membranous glomerulonephritis serum VEGF correlated positively with 24-hour proteinuria excretion .

  12. 本实验表明Captopril能减少糖尿病肾病尿蛋白排出。

    Our results indicated that Captopril may reduce excretion of urine protein in diabetic nephropathy .

  13. GDM对女运动员血红蛋白和运动后尿蛋白的影响

    Effect of GDM on Female Athletes ' Hemoglobin and Albuminuria After Exercise

  14. 结论随机尿蛋白/血清胱抑素C比值可替代24h尿蛋白定量。

    Conclusion It is suggested that the ratio of random urine protein / serum cystatin C can replace the detection of 24-hour urine quantitative protein .

  15. 结果①两组血清胱抑素C值及24h尿蛋白治疗后均降低,治疗前后差异有显著性(P<0.01);

    Results Serum level of CC and 24h urine protein in the two groups were significantly lower than those before medication ( P < 0.01 ) .

  16. 两组用药各30d。治疗前后测定24h尿蛋白。

    24-hour urinary protein measure was done before and after the treatment in both groups .

  17. 结果缬沙坦和苯那普利治疗组的尿蛋白显著减少(P<0.01),且缬沙坦作用较苯那普利更显著(P<0.05);

    Results The excretion of proteinuria significantly decreased in the treating groups compared to control group ( P < 0 . 01 ), and was further lower in valsartan group ( P < 0 . 05 ) .

  18. 目的:探讨尿蛋白定性阴性的糖尿病肾病(DN)患者随机尿中三种微量蛋白检测对发现糖尿病早期肾损害的意义。

    Objective To discover early renal disease of diabetes mellitus ( DM ) by determining three microproteins in random urine .

  19. 用生化方法测定血糖、血胆固醇、血尿素氮、血肌酐及24小时尿蛋白定量;用RT-PCR和免疫组化方法测定肾组织TGF-β1基因和蛋白水平的表达。

    The levels of blood glucose 、 plasma cholesterol 、 serum BUN 、 serum creatinine and 24 hours proteinuria analysis were measured by biochemistry method .

  20. 结果B组其24hUAER显著下降(P<0.05)。结论依那普利可降低尿蛋白排泄量,其不良反应少,可作为预防和治疗糖尿病早期肾病的药物。

    Results The UAER of group B was decreased P < 0.05 . Conclusion The enalapril might decrease the UAER with less side effect and could be the drug of prevention and treatment in early stage .

  21. 方法检测107例不同肾脏疾病患者的24h尿蛋白定量、晨尿尿蛋白/尿肌酐比值和尿蛋白/尿渗透压比值,并进行相关性分析。

    Methods Urine samples of 107 patients with renal diseases were analyzed for 24h urinary protein , protein-osmolality ratio and protein-creatinine ratio .

  22. 其中血脂、血粘度明显改善(P均<0.05),Cr、BUN、尿蛋白极显著改善(P均<0.01)。

    Particularly , blood lipid and blood viscosity were improved significantly ( all P 0 05 ) . Cr , BUN and urinary protein were improved extremely ( all P 0 01 ) .

  23. 结果:肾功能不良的MM患者,用血清指标(肌肝、尿素)评估只有19例(28.3%),而用尿蛋白评估是46例(68.7%)。

    Results Renal dysfunction evaluated with serum parameters ( creatinine , urea ) was presented in 19 patients ( 28.3 % ), while urinary proteins in 46 patients ( 68.7 % ) .

  24. 结论早期DN的治疗中使用氯沙坦,可以降低尿蛋白排泄,阻止肾脏损害的发展,保护肾功能。

    Conclusion Losartan tablets can decrease the excretion of urinary protein , inhibit progression of kidney damage , and keep normal renal function .

  25. 以上结果提示,Captopril具有减少尿蛋白排泄及抗脂质过氧化作用。

    The results suggest that captopril can reduce the albuminuria of patients with early diabetic nephropathy and had an anti-lipid peroxide effect .

  26. 芒果苷各组与模型组相比,血糖和24-h尿蛋白明显下降(P0.01),SOD活性增加(P0.05或P0.01)。

    Fasting blood glucose and 24-h urinary protein of mangiferin groups were significantly decreased ( P0.01 ), SOD activity was increased ( P0.05 or P0.01 ) .

  27. MEL治疗能够部分改善肾功能,显著减少尿蛋白的排泄,延缓进入肾功能衰竭期;形态学上可以减轻系膜基质的增生、肾小球硬化和肾间质纤维化。

    The melatonin could partly ameliorated renal function , predominantly reduced urinary protein excretion and retarded the appearance of renal failure .

  28. 结论PGE1有减少肾病综合征尿蛋白的作用。

    Conclusions The results show that PGE 1 has therapeutic effects on PNS by decreasing urinary protein .

  29. 方法:59例妊娠期高血压疾病患者,选择正常非妊娠妇女22例及正常孕晚期妇女35例作为对照组,检测血浆中FN、Cr、BUN及尿蛋白水平进行统计分析。

    Methods : FN 、 Cr 、 BUN and proteinuria were examined in 35 normal late-pregnancy women 、 22 non-pregnancy women and 59 patients with gestational hypertensive .

  30. 于用药前后监测患者血流变化及尿蛋白变化,胎儿宫内状态及产后2h出血量。

    Then the variation of blood flow , urinary protein , intrauterine state and amount of bleeding in 2 hours after bearing were monitored .